PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+5.38%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.64B
AUM Growth
-$53.3M
(-2%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
36.54%
Holding
1,168
New
94
Increased
480
Reduced
555
Closed
36
Top Buys
| 1 |
Apple
AAPL
|
$4.55M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$1.79M |
| 3 |
ConocoPhillips
COP
|
$1.73M |
| 4 |
Insmed
INSM
|
$1.69M |
| 5 |
Super Micro Computer
SMCI
|
$1.63M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$51.6M |
| 2 |
Microsoft
MSFT
|
$20.2M |
| 3 |
Broadcom
AVGO
|
$9.75M |
| 4 |
Meta Platforms (Facebook)
META
|
$6.72M |
| 5 |
Amazon
AMZN
|
$5.69M |
Sector Composition
| 1 | Technology | 43.4% |
| 2 | Healthcare | 11.97% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Communication Services | 9.11% |
| 5 | Financials | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Wipro
WIT
$28.4B
| $161K | 0.01% |
49,560
-6,112
| -11% | -$19.8K |
|
1077
Anavex Life Sciences
AVXL
$807M
| $159K | 0.01% |
27,973
-13,307
| -32% | -$75.6K |
|
1078
Tango Therapeutics
TNGX
$771M
| $158K | 0.01% |
20,473
+6,580
| +47% | +$50.7K |
|
1079
Cushman & Wakefield
CWK
$3.82B
| $158K | 0.01% |
11,565
+1,469
| +15% | +$20K |
|
1080
Ocugen
OCGN
$319M
| $155K | 0.01% |
156,167
+9,525
| +6% | +$9.45K |
|
1081
RPC Inc
RES
$1.04B
| $152K | 0.01% |
23,889
-8,240
| -26% | -$52.4K |
|
1082
Cleveland-Cliffs
CLF
$5.55B
| $152K | 0.01% |
11,869
-458
| -4% | -$5.85K |
|
1083
Fate Therapeutics
FATE
$112M
| $149K | 0.01% |
42,652
-3,876
| -8% | -$13.6K |
|
1084
Genworth Financial
GNW
$3.51B
| $149K | 0.01% |
21,774
+789
| +4% | +$5.41K |
|
|
ALTM
1085
DELISTED
Arcadium Lithium plc
ALTM
| $149K | 0.01% |
52,201
+1,915
| +4% | +$5.46K |
|
1086
LXP Industrial Trust
LXP
$2.68B
| $149K | 0.01% |
14,779
+719
| +5% | +$7.23K |
|
1087
Savara
SVRA
$638M
| $145K | 0.01% |
34,215
+8,198
| +32% | +$34.8K |
|
1088
Neumora Therapeutics
NMRA
$275M
| $143K | 0.01% |
+10,828
| New | +$143K |
|
1089
MiMedx Group
MDXG
$1.06B
| $139K | 0.01% |
23,516
-3,379
| -13% | -$20K |
|
1090
Oric Pharmaceuticals
ORIC
$1.07B
| $138K | 0.01% |
13,502
-8,359
| -38% | -$85.7K |
|
1091
First Majestic Silver
AG
$4.51B
| $135K | 0.01% |
22,548
+837
| +4% | +$5.02K |
|
1092
Hanesbrands
HBI
$2.25B
| $131K | ﹤0.01% |
17,785
+867
| +5% | +$6.37K |
|
1093
Erasca
ERAS
$443M
| $130K | ﹤0.01% |
+47,626
| New | +$130K |
|
1094
Liquidia Corp
LQDA
$2.5B
| $129K | ﹤0.01% |
12,942
-1,492
| -10% | -$14.9K |
|
1095
Fulcrum Therapeutics
FULC
$414M
| $124K | ﹤0.01% |
34,846
+23,925
| +219% | +$85.4K |
|
1096
Astria Therapeutics
ATXS
$406M
| $122K | ﹤0.01% |
11,038
-9,361
| -46% | -$103K |
|
1097
MindMed
MNMD
$687M
| $119K | ﹤0.01% |
20,843
-3
| -0% | -$17 |
|
1098
Goodyear
GT
$2.41B
| $117K | ﹤0.01% |
13,185
+127
| +1% | +$1.12K |
|
1099
Aurora
AUR
$10.5B
| $116K | ﹤0.01% |
19,584
+2,834
| +17% | +$16.8K |
|
1100
Pliant Therapeutics
PLRX
$108M
| $113K | ﹤0.01% |
+10,077
| New | +$113K |
|